Starpax Biopharma Inc. — Regulation A 1-A
Starpax Biopharma Inc. of MONTREAL, A8 filed a Regulation A 1-A with the SEC on 2023-02-09. Aggregate offering: $25.0M (Tier 2). Industry: Other.
Offering
- Filed: 2023-02-09
- Form: 1-A
- Accession: 0001960682-23-000001
- Tier: Tier 2
- Total aggregate offering: $25.0M
- Issuer portion: $25.0M
- Price per security: $6.2500
- Securities offered: Equity (common or preferred stock)
- Audit status: Audited
- Auditor: SRCO Professional Corporation
- Jurisdictions: 128 states/territories
Issuer
- CIK: 0001960682
- Organized in: A8
- Incorporated: 2017
- Address: 2500-1000 BOUL. RENE-LEVESQUE WEST, MONTREAL, A8, H3B 5C9
- Phone: 5144273004
- Employees: 40 full-time, 4 part-time
Financial snapshot (as filed)
- Total assets: $27.3M
- Cash & equivalents: $4.8M
- Total liabilities: $8.3M
- Stockholder equity: $19.0M
- Net income: $-3.5M
People (2)
| Name | Role | Location |
|---|
| Nicholas Antaki | Signer | SCOTTSDALE, AZ |
| Michael Gareau | Director and Chief Executive Officer | Montreal, A8 |
Other Reg A filings by this issuer (4)
More